UnitedHealth Group Inc (NYSE:UNH) Director Richard T. Burke sold 10,000 shares of the business’s stock in a transaction that occurred on Monday, March 19th. The stock was sold at an average price of $224.36, for a total transaction of $2,243,600.00. Following the sale, the director now directly owns 1,771,257 shares of the company’s stock, valued at $397,399,220.52. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.
UNH stock opened at $212.55 on Friday. UnitedHealth Group Inc has a 1-year low of $162.74 and a 1-year high of $250.79. The company has a market cap of $215,614.66, a price-to-earnings ratio of 19.85, a P/E/G ratio of 1.30 and a beta of 0.74. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.58.
UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.50 by $0.09. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The business had revenue of $52.06 billion during the quarter, compared to analysts’ expectations of $51.57 billion. During the same quarter in the prior year, the company posted $2.11 earnings per share. The firm’s revenue was up 9.5% on a year-over-year basis. analysts forecast that UnitedHealth Group Inc will post 12.51 EPS for the current fiscal year.
A number of institutional investors and hedge funds have recently made changes to their positions in UNH. Capital International Investors boosted its holdings in UnitedHealth Group by 399.3% during the third quarter. Capital International Investors now owns 4,132,602 shares of the healthcare conglomerate’s stock worth $809,370,000 after purchasing an additional 3,304,902 shares during the last quarter. Jennison Associates LLC raised its position in UnitedHealth Group by 146.0% during the third quarter. Jennison Associates LLC now owns 5,541,977 shares of the healthcare conglomerate’s stock worth $1,085,396,000 after acquiring an additional 3,289,470 shares in the last quarter. Janus Henderson Group PLC raised its position in UnitedHealth Group by 1,820.1% during the second quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock worth $442,896,000 after acquiring an additional 2,264,242 shares in the last quarter. Egerton Capital UK LLP bought a new stake in UnitedHealth Group during the fourth quarter worth $368,905,000. Finally, Vanguard Group Inc. raised its position in UnitedHealth Group by 2.5% during the second quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock worth $11,974,168,000 after acquiring an additional 1,588,516 shares in the last quarter. Institutional investors and hedge funds own 86.78% of the company’s stock.
UNH has been the subject of a number of recent research reports. Credit Suisse Group reissued a “buy” rating on shares of UnitedHealth Group in a research note on Wednesday, December 27th. Evercore ISI restated an “outperform” rating and set a $255.00 price objective (up previously from $235.00) on shares of UnitedHealth Group in a report on Friday, January 12th. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 price objective for the company in a report on Saturday, January 20th. Wells Fargo restated an “outperform” rating and set a $245.00 price objective (up previously from $230.00) on shares of UnitedHealth Group in a report on Wednesday, November 29th. Finally, ValuEngine cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, December 7th. Two research analysts have rated the stock with a hold rating and twenty-six have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $244.62.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.